Extracellular ATP and adenosine: The Yin and Yang in immune responses?

Molecular Aspects of Medicine

Volumn 55, Issue , 2017, Pages 9-19

  Faas, M M ^a   Saez T ^a,b   de Vos, P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Adenosine; ATP; Immune response; Inflammation

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE TRIPHOSPHATE; CD39 ANTIGEN; INTERLEUKIN 1BETA; NUCLEOTIDE TRANSPORTER; PICLIDENOSON; PLACEBO; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; ADENOSINE RECEPTOR; APYRASE; LEUKOCYTE ANTIGEN;

ATHEROGENESIS; ATHEROSCLEROSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENDOTHELIUM CELL; ENTERITIS; GRANULOCYTE; HUMAN; HYPOXEMIA; IMMUNE RESPONSE; INFLAMMATION; INTRACELLULAR SIGNALING; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MAST CELL; MONOCYTE; NONHUMAN; PREECLAMPSIA; PREGNANCY; REVIEW; RHEUMATOID ARTHRITIS; TUMOR GROWTH; VIRUS ENTRY; VIRUS INFECTION; CELLULAR IMMUNITY; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE TRIPHOSPHATE; ANTIGENS, CD; APYRASE; ENDOTHELIAL CELLS; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2X; RECEPTORS, PURINERGIC P2Y;

EID: 85009732787     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2017.01.002     Document Type: Review

References (198)

1. Aalto, T.K., Raivio, K.O., Metabolism of extracellular adenine nucleotides by human endothelial cells exposed to reactive oxygen metabolites. Am. J. Physiol. 264:2 Pt 1 (1993), C282–C286.
2. Aandahl, E.M., Michaelsson, J., Moretto, W.J., Hecht, F.M., Nixon, D.F., Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78:5 (2004), 2454–2459.
3. Abbracchio, M.P., Burnstock, G., Boeynaems, J.M., Barnard, E.A., Boyer, J.L., Kennedy, C., Knight, G.E., Fumagalli, M., Gachet, C., Jacobson, K.A., Weisman, G.A., International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 58:3 (2006), 281–341.
4. Al-Shukaili, A., Al-Kaabi, J., Hassan, B., Al-Araimi, T., Al-Tobi, M., Al-Kindi, M., Al-Maniri, A., Al-Gheilani, A., Al-Ansari, A., P2X7 receptor gene polymorphism analysis in rheumatoid arthritis. Int. J. Immunogenet 38:5 (2011), 389–396.
5. Anderson, P., Rohlich, P., Slorach, S.A., Uvnas, B., Morphology and storage properties of rat mast cell granules isolated by different methods. Acta Physiol. Scand. 91:2 (1974), 145–153.
6. Antonioli, L., Csoka, B., Fornai, M., Colucci, R., Kokai, E., Blandizzi, C., Hasko, G., Adenosine and inflammation: what's new on the horizon. Drug Discov. Today 19:8 (2014), 1051–1068.
7. Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y., Yamamoto, M., Onoue, M., Yagita, H., Ishii, N., Evans, R., Honda, K., Takeda, K., ATP drives lamina propria T(H)17 cell differentiation. Nature 455:7214 (2008), 808–812.
8. Axtell, R.A., Sandborg, R.R., Smolen, J.E., Ward, P.A., Boxer, L.A., Exposure of human neutrophils to exogenous nucleotides causes elevation in intracellular calcium, transmembrane calcium fluxes, and an alteration of a cytosolic factor resulting in enhanced superoxide production in response to FMLP and arachidonic acid. Blood 75:6 (1990), 1324–1332.
9. Bahamonde, M.I., Valverde, M.A., Voltage-dependent anion channel localises to the plasma membrane and peripheral but not perinuclear mitochondria. Pflugers Arch. 446:3 (2003), 309–313.
10. Baharav, E., Bar-Yehuda, S., Madi, L., Silberman, D., Rath-Wolfson, L., Halpren, M., Ochaion, A., Weinberger, A., Fishman, P., Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models. J. Rheumatol. 32:3 (2005), 469–476.
11. Bakker, W.W., Donker, R.B., Timmer, A., van Pampus, M.G., van Son, W.J., Aarnoudse, J.G., van Goor, H., Niezen-Koning, K.E., Navis, G., Borghuis, T., Jongman, R.M., Faas, M.M., Plasma hemopexin activity in pregnancy and pre-eclampsia. Hypertens. Pregnancy 26:2 (2007), 227–239.
12. Bao, L., Locovei, S., Dahl, G., Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett. 572:1–3 (2004), 65–68.
13. Bao, R., Hou, J., Li, Y., Bian, J., Deng, X., Zhu, X., Yang, T., Adenosine promotes Foxp3 expression in Treg cells in sepsis model by activating JNK/AP-1 pathway. Am. J. Transl. Res. 8:5 (2016), 2284–2292.
14. Barletta, K.E., Ley, K., Mehrad, B., Regulation of neutrophil function by adenosine. Arterioscler. Thromb. Vasc. Biol. 32:4 (2012), 856–864.
15. Bastid, J., Cottalorda-Regairaz, A., Alberici, G., Bonnefoy, N., Eliaou, J.F., Bensussan, A., ENTPD1/CD39 is a promising therapeutic target in oncology. Oncogene 32:14 (2013), 1743–1751.
16. Bianchi, M.E., DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81:1 (2007), 1–5.
17. Bobryshev, Y.V., Ivanova, E.A., Chistiakov, D.A., Nikiforov, N.G., Orekhov, A.N., Macrophages and their role in atherosclerosis: pathophysiology and transcriptome analysis. Biomed. Res. Int., 2016, 2016, 9582430.
18. Bodin, P., Burnstock, G., Increased release of ATP from endothelial cells during acute inflammation. Inflamm. Res. 47:8 (1998), 351–354.
19. Bodin, P., Burnstock, G., Evidence that release of adenosine triphosphate from endothelial cells during increased shear stress is vesicular. J. Cardiovasc Pharmacol. 38:6 (2001), 900–908.
20. Bouma, M.G., Stad, R.K., van den Wildenberg, F.A., Buurman, W.A., Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153:9 (1994), 4159–4168.
21. Bours, M.J., Swennen, E.L., Di Virgilio, F., Cronstein, B.N., Dagnelie, P.C., Adenosine 5’-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112:2 (2006), 358–404.
22. Brigati, C., Noonan, D.M., Albini, A., Benelli, R., Tumors and inflammatory infiltrates: friends or foes?. Clin. Exp. Metastasis 19:3 (2002), 247–258.
23. Burnstock, G., Purinergic signalling in the gut. Adv. Exp. Med. Biol. 891 (2016), 91–112.
24. Burnstock, G., Di Virgilio, F., Purinergic signalling and cancer. Purinergic Signal 9:4 (2013), 491–540.
25. Burow, P., Klapperstuck, M., Markwardt, F., Activation of ATP secretion via volume-regulated anion channels by sphingosine-1-phosphate in RAW macrophages. Pflugers Arch. 467:6 (2015), 1215–1226.
26. Bynoe, M.S., Waickman, A.T., Mahamed, D.A., Mueller, C., Mills, J.H., Czopik, A., CD73 is critical for the resolution of murine colonic inflammation. J. Biomed. Biotechnol., 2012, 2012, 260983.
27. Cannon, C.P., Harrington, R.A., James, S., Ardissino, D., Becker, R.C., Emanuelsson, H., Husted, S., Katus, H., Keltai, M., Khurmi, N.S., Kontny, F., Lewis, B.S., Steg, P.G., Storey, R.F., Wojdyla, D., Wallentin, L., inhibition, P.L., patient Outcomes, I. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet 375:9711 (2010), 283–293.
28. Cekic, C., Sag, D., Li, Y., Theodorescu, D., Strieter, R.M., Linden, J., Adenosine A2B receptor blockade slows growth of bladder and breast tumors. J. Immunol. 188:1 (2012), 198–205.
29. Chekeni, F.B., Elliott, M.R., Sandilos, J.K., Walk, S.F., Kinchen, J.M., Lazarowski, E.R., Armstrong, A.J., Penuela, S., Laird, D.W., Salvesen, G.S., Isakson, B.E., Bayliss, D.A., Ravichandran, K.S., Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis. Nature 467:7317 (2010), 863–867.
30. Chen, L., Brosnan, C.F., Regulation of immune response by P2X7 receptor. Crit. Rev. Immunol. 26:6 (2006), 499–513.
31. Chen, Y., Bao, Y., Zhang, J., Woehrle, T., Sumi, Y., Ledderose, S., Li, X., Ledderose, C., Junger, W.G., Inhibition of neutrophils by hypertonic saline involves Pannexin-1, CD39, CD73, and other ectonucleotidases. Shock 44:3 (2015), 221–227.
32. Chen, Y., Corriden, R., Inoue, Y., Yip, L., Hashiguchi, N., Zinkernagel, A., Nizet, V., Insel, P.A., Junger, W.G., ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314:5806 (2006), 1792–1795.
33. Contreras, J.E., Saez, J.C., Bukauskas, F.F., Bennett, M.V., Functioning of cx43 hemichannels demonstrated by single channel properties. Cell Commun. Adhes. 10:4–6 (2003), 245–249.
34. Corthay, A., How do regulatory T cells work?. Scand. J. Immunol. 70:4 (2009), 326–336.
35. Coutinho-Silva, R., Knight, G.E., Burnstock, G., Impairment of the splenic immune system in P2X(2)/P2X(3) knockout mice. Immunobiology 209:9 (2005), 661–668.
36. Cruz, C.M., Rinna, A., Forman, H.J., Ventura, A.L., Persechini, P.M., Ojcius, D.M., ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 282:5 (2007), 2871–2879.
37. Csoka, B., Himer, L., Selmeczy, Z., Vizi, E.S., Pacher, P., Ledent, C., Deitch, E.A., Spolarics, Z., Nemeth, Z.H., Hasko, G., Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function. FASEB J. 22:10 (2008), 3491–3499.
38. Day, Y.J., Huang, L., McDuffie, M.J., Rosin, D.L., Ye, H., Chen, J.F., Schwarzschild, M.A., Fink, J.S., Linden, J., Okusa, M.D., Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J. Clin. Invest. 112:6 (2003), 883–891.
39. De Vuyst, E., Decrock, E., Cabooter, L., Dubyak, G.R., Naus, C.C., Evans, W.H., Leybaert, L., Intracellular calcium changes trigger connexin 32 hemichannel opening. EMBO J. 25:1 (2006), 34–44.
40. Deaglio, S., Dwyer, K.M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.F., Enjyoji, K., Linden, J., Oukka, M., Kuchroo, V.K., Strom, T.B., Robson, S.C., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204:6 (2007), 1257–1265.
41. Dean, G.E., Fishkes, H., Nelson, P.J., Rudnick, G., The hydrogen ion-pumping adenosine triphosphatase of platelet dense granule membrane. Differences from F1F0- and phosphoenzyme-type ATPases. J. Biol. Chem. 259:15 (1984), 9569–9574.
42. DeNardo, D.G., Andreu, P., Coussens, L.M., Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev. 29:2 (2010), 309–316.
43. Di Virgilio, F., The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol. Today 16:11 (1995), 524–528.
44. Di Virgilio, F., Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol. Sci. 28:9 (2007), 465–472.
45. Di Virgilio, F., Adinolfi, E., Extracellular purines, purinergic receptors and tumor growth. Oncogene, 2016.
46. Di Virgilio, F., Boeynaems, J.M., Robson, S.C., Extracellular nucleotides as negative modulators of immunity. Curr. Opin. Pharmacol. 9:4 (2009), 507–513.
47. Di Virgilio, F., Bronte, V., Collavo, D., Zanovello, P., Responses of mouse lymphocytes to extracellular adenosine 5’-triphosphate (ATP). Lymphocytes with cytotoxic activity are resistant to the permeabilizing effects of ATP. J. Immunol. 143:6 (1989), 1955–1960.
48. Di Virgilio, F., Pizzo, P., Zanovello, P., Bronte, V., Collavo, D., Extracellular ATP as a possible mediator of cell-mediated cytotoxicity. Immunol. Today 11:8 (1990), 274–277.
49. Di Virgilio, F., Vuerich, M., Purinergic signaling in the immune system. Auton. Neurosci. 191 (2015), 117–123.
50. Diezmos, E.F., Bertrand, P.P., Liu, L., Purinergic signaling in gut inflammation: the role of connexins and pannexins. Front. Neurosci., 10, 2016, 311.
51. Duley, L., The global impact of pre-eclampsia and eclampsia. Semin. Perinatol. 33:3 (2009), 130–137.
52. Dutta, A.K., Sabirov, R.Z., Uramoto, H., Okada, Y., Role of ATP-conductive anion channel in ATP release from neonatal rat cardiomyocytes in ischaemic or hypoxic conditions. J. Physiol. 559:Pt 3 (2004), 799–812.
53. Eckle, T., Fullbier, L., Wehrmann, M., Khoury, J., Mittelbronn, M., Ibla, J., Rosenberger, P., Eltzschig, H.K., Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J. Immunol. 178:12 (2007), 8127–8137.
54. Eltzschig, H.K., Abdulla, P., Hoffman, E., Hamilton, K.E., Daniels, D., Schonfeld, C., Loffler, M., Reyes, G., Duszenko, M., Karhausen, J., Robinson, A., Westerman, K.A., Coe, I.R., Colgan, S.P., HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J. Exp. Med. 202:11 (2005), 1493–1505.
55. Erlinge, D., Burnstock, G., P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4:1 (2008), 1–20.
56. Faas, M.M., Spaans, F., De Vos, P., Monocytes and macrophages in pregnancy and pre-eclampsia. Front. Immunol., 5, 2014, 298.
57. Faas, M.M., van der Schaaf, G., Borghuis, T., Jongman, R.M., van Pampus, M.G., de Vos, P., van Goor, H., Bakker, W.W., Extracellular ATP induces albuminuria in pregnant rats. Nephrol. Dial. Transpl, 11, 2010.
58. Falzoni, S., Donvito, G., Di Virgilio, F., Detecting adenosine triphosphate in the pericellular space. Interface Focus, 3(3), 2013, 20120101.
59. Feoktistov, I., Biaggioni, I., Adenosine A2B receptors. Pharmacol. Rev. 49:4 (1997), 381–402.
60. Ferrari, D., Chiozzi, P., Falzoni, S., Dal Susino, M., Melchiorri, L., Baricordi, O.R., Di Virgilio, F., Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159:3 (1997), 1451–1458.
61. Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R.M., Curti, A., Idzko, M., Panther, E., Di Virgilio, F., The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176:7 (2006), 3877–3883.
62. Fishman, P., Cohen, S., The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis. Clin. Rheumatol. 35:9 (2016), 2359–2362.
63. Forrest, C.M., Harman, G., McMillan, R.B., Stoy, N., Stone, T.W., Darlington, L.G., Modulation of cytokine release by purine receptors in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 23:1 (2005), 89–92.
64. Franceschini, A., Capece, M., Chiozzi, P., Falzoni, S., Sanz, J.M., Sarti, A.C., Bonora, M., Pinton, P., Di Virgilio, F., The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein. FASEB J. 29:6 (2015), 2450–2461.
65. Friedman, D.J., Kunzli, B.M., A-Rahim, Y.I., Sevigny, J., Berberat, P.O., Enjyoji, K., Csizmadia, E., Friess, H., Robson, S.C., From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc. Natl. Acad. Sci. U. S. A. 106:39 (2009), 16788–16793.
66. Gallucci, S., Matzinger, P., Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13:1 (2001), 114–119.
67. Gimenez-Llort, L., Fernandez-Teruel, A., Escorihuela, R.M., Fredholm, B.B., Tobena, A., Pekny, M., Johansson, B., Mice lacking the adenosine A1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate. Eur. J. Neurosci. 16:3 (2002), 547–550.
68. Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Blaha, M.J., Dai, S., Ford, E.S., Fox, C.S., Franco, S., Fullerton, H.J., Gillespie, C., Hailpern, S.M., Heit, J.A., Howard, V.J., Huffman, M.D., Judd, S.E., Kissela, B.M., Kittner, S.J., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Mackey, R.H., Magid, D.J., Marcus, G.M., Marelli, A., Matchar, D.B., McGuire, D.K., Mohler, E.R., 3rd, Moy, C.S., Mussolino, M.E., Neumar, R.W., Nichol, G., Pandey, D.K., Paynter, N.P., Reeves, M.J., Sorlie, P.D., Stein, J., Towfighi, A., Turan, T.N., Virani, S.S., Wong, N.D., Woo, D., Turner, M.B., American heart association statistics, C., stroke statistics, S., 2014. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation 129(3), e28–e292.
69. Gualix, J., Pintor, J., Miras-Portugal, M.T., Characterization of nucleotide transport into rat brain synaptic vesicles. J. Neurochem. 73:3 (1999), 1098–1104.
70. Gulbransen, B.D., Bashashati, M., Hirota, S.A., Gui, X., Roberts, J.A., MacDonald, J.A., Muruve, D.A., McKay, D.M., Beck, P.L., Mawe, G.M., Thompson, R.J., Sharkey, K.A., Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat. Med. 18:4 (2012), 600–604.
71. Haefliger, J.A., Nicod, P., Meda, P., Contribution of connexins to the function of the vascular wall. Cardiovasc Res. 62:2 (2004), 345–356.
72. Hansson, G.K., Libby, P., Schonbeck, U., Yan, Z.Q., Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91:4 (2002), 281–291.
73. Hashimoto, E., Kage, K., Ogita, T., Nakaoka, T., Matsuoka, R., Kira, Y., Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells. Biochem. Biophys. Res. Commun. 204:1 (1994), 318–324.
74. Hasko, G., Kuhel, D.G., Chen, J.F., Schwarzschild, M.A., Deitch, E.A., Mabley, J.G., Marton, A., Szabo, C., Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. 14:13 (2000), 2065–2074.
75. Hasko, G., Kuhel, D.G., Salzman, A.L., Szabo, C., ATP suppression of interleukin-12 and tumour necrosis factor-alpha release from macrophages. Br. J. Pharmacol. 129:5 (2000), 909–914.
76. Hasko, G., Pacher, P., Regulation of macrophage function by adenosine. Arterioscler. Thromb. Vasc. Biol. 32:4 (2012), 865–869.
77. Hasko, G., Pacher, P., Deitch, E.A., Vizi, E.S., Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol. Ther. 113:2 (2007), 264–275.
78. Hasko, G., Szabo, C., Nemeth, Z.H., Kvetan, V., Pastores, S.M., Vizi, E.S., Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 157:10 (1996), 4634–4640.
79. Hazleton, J.E., Berman, J.W., Eugenin, E.A., Purinergic receptors are required for HIV-1 infection of primary human macrophages. J. Immunol. 188:9 (2012), 4488–4495.
80. Hechler, B., Freund, M., Ravanat, C., Magnenat, S., Cazenave, J.P., Gachet, C., Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors. Circulation 118:7 (2008), 754–763.
81. Herve, J.C., The connexins. Biochim. Biophys. Acta 1662:1–2 (2004), 1–2.
82. Hill, L.M., Gavala, M.L., Lenertz, L.Y., Bertics, P.J., Extracellular ATP may contribute to tissue repair by rapidly stimulating purinergic receptor X7-dependent vascular endothelial growth factor release from primary human monocytes. J. Immunol. 185:5 (2010), 3028–3034.
83. Hirschhorn, R., Ratech, H., Isozymes of adenosine deaminase. Isozymes Curr. Top. Biol. Med. Res. 4 (1980), 131–157.
84. Hisadome, K., Koyama, T., Kimura, C., Droogmans, G., Ito, Y., Oike, M., Volume-regulated anion channels serve as an auto/paracrine nucleotide release pathway in aortic endothelial cells. J. Gen. Physiol. 119:6 (2002), 511–520.
85. Hogquist, K.A., Nett, M.A., Unanue, E.R., Chaplin, D.D., Interleukin 1 is processed and released during apoptosis. Proc. Natl. Acad. Sci. U. S. A. 88:19 (1991), 8485–8489.
86. Huang, N., Wang, D.J., Heppel, L.A., Extracellular ATP is a mitogen for 3T3, 3T6, and A431 cells and acts synergistically with other growth factors. Proc. Natl. Acad. Sci. U. S. A. 86:20 (1989), 7904–7908.
87. Idzko, M., Ferrari, D., Eltzschig, H.K., Nucleotide signalling during inflammation. Nature 509:7500 (2014), 310–317.
88. Islam, M.R., Uramoto, H., Okada, T., Sabirov, R.Z., Okada, Y., Maxi-anion channel and pannexin 1 hemichannel constitute separate pathways for swelling-induced ATP release in murine L929 fibrosarcoma cells. Am. J. Physiol. Cell Physiol. 303:9 (2012), C924–C935.
89. Iwase, T., Shinji, H., Tajima, A., Sato, F., Tamura, T., Iwamoto, T., Yoneda, M., Mizunoe, Y., Isolation and identification of ATP-secreting bacteria from mice and humans. J. Clin. Microbiol. 48:5 (2010), 1949–1951.
90. Iwata, M., Ota, K.T., Li, X.Y., Sakaue, F., Li, N., Dutheil, S., Banasr, M., Duric, V., Yamanashi, T., Kaneko, K., Rasmussen, K., Glasebrook, A., Koester, A., Song, D., Jones, K.A., Zorn, S., Smagin, G., Duman, R.S., Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor. Biol. Psychiatry 80:1 (2016), 12–22.
91. Jacob, F., Perez Novo, C., Bachert, C., Van Crombruggen, K., Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses. Purinergic Signal 9:3 (2013), 285–306.
92. Jalkanen, J., Yegutkin, G.G., Hollmen, M., Aalto, K., Kiviniemi, T., Salomaa, V., Jalkanen, S., Hakovirta, H., Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis. Circ. Res. 116:7 (2015), 1206–1215.
93. Johansson, B., Halldner, L., Dunwiddie, T.V., Masino, S.A., Poelchen, W., Gimenez-Llort, L., Escorihuela, R.M., Fernandez-Teruel, A., Wiesenfeld-Hallin, Z., Xu, X.J., Hardemark, A., Betsholtz, C., Herlenius, E., Fredholm, B.B., Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. U. S. A. 98:16 (2001), 9407–9412.
94. Jones, M.R., Zhao, Z., Sullivan, C.P., Schreiber, B.M., Stone, P.J., Toselli, P.A., Kagan, H.M., Cohen, R.A., Ravid, K., A(3) adenosine receptor deficiency does not influence atherogenesis. J. Cell Biochem. 92:5 (2004), 1034–1043.
95. Junger, W.G., Immune cell regulation by autocrine purinergic signalling. Nat. Rev. Immunol. 11:3 (2011), 201–212.
96. Kalsi, K., Lawson, C., Dominguez, M., Taylor, P., Yacoub, M.H., Smolenski, R.T., Regulation of ecto-5’-nucleotidase by TNF-alpha in human endothelial cells. Mol. Cell Biochem. 232:1–2 (2002), 113–119.
97. Kanneganti, T.D., Lamkanfi, M., Nunez, G., Intracellular NOD-like receptors in host defense and disease. Immunity 27:4 (2007), 549–559.
98. Kang, J., Kang, N., Lovatt, D., Torres, A., Zhao, Z., Lin, J., Nedergaard, M., Connexin 43 hemichannels are permeable to ATP. J. Neurosci. 28:18 (2008), 4702–4711.
99. Khakh, B.S., North, R.A., P2X receptors as cell-surface ATP sensors in health and disease. Nature 442:7102 (2006), 527–532.
100. Killeen, M.E., Ferris, L., Kupetsky, E.A., Falo, L. Jr., Mathers, A.R., Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis. J. Immunol. 190:8 (2013), 4324–4336.
101. Kitakaze, M., Hori, M., Morioka, T., Takashima, S., Minamino, T., Sato, H., Inoue, M., Kamada, T., Attenuation of ecto-5’-nucleotidase activity and adenosine release in activated human polymorphonuclear leukocytes. Circ. Res. 73:3 (1993), 524–533.
102. Kitakaze, M., Hori, M., Takashima, S., Morioka, T., Minamino, T., Sato, H., Okazaki, Y., Inoue, M., Kamada, T., Superoxide dismutase enhances both adenosine release and coronary hyperemic flow through protection of 5’-nucleotidase against its degradation during reperfusion following ischemia in dogs. Biorheology 30:5–6 (1993), 359–370.
103. Kolb, H.A., Ubl, J., Activation of anion channels by zymosan particles in membranes of peritoneal macrophages. Biochim. Biophys. Acta 899:2 (1987), 239–246.
104. Koscso, B., Csoka, B., Selmeczy, Z., Himer, L., Pacher, P., Virag, L., Hasko, G., Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated process. J. Immunol. 188:1 (2012), 445–453.
105. Koupenova, M., Johnston-Cox, H., Vezeridis, A., Gavras, H., Yang, D., Zannis, V., Ravid, K., A2b adenosine receptor regulates hyperlipidemia and atherosclerosis. Circulation 125:2 (2012), 354–363.
106. Kronlage, M., Song, J., Sorokin, L., Isfort, K., Schwerdtle, T., Leipziger, J., Robaye, B., Conley, P.B., Kim, H.C., Sargin, S., Schon, P., Schwab, A., Hanley, P.J., Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci. Signal, 3(132), 2010, ra55.
107. Kurashima, Y., Amiya, T., Nochi, T., Fujisawa, K., Haraguchi, T., Iba, H., Tsutsui, H., Sato, S., Nakajima, S., Iijima, H., Kubo, M., Kunisawa, J., Kiyono, H., Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors. Nat. Commun., 3, 2012, 1034.
108. Kusu, T., Kayama, H., Kinoshita, M., Jeon, S.G., Ueda, Y., Goto, Y., Okumura, R., Saiga, H., Kurakawa, T., Ikeda, K., Maeda, Y., Nishimura, J., Arima, Y., Atarashi, K., Honda, K., Murakami, M., Kunisawa, J., Kiyono, H., Okumura, M., Yamamoto, M., Takeda, K., Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestine. J. Immunol. 190:2 (2013), 774–783.
109. la Sala, A., Ferrari, D., Corinti, S., Cavani, A., Di Virgilio, F., Girolomoni, G., Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J. Immunol. 166:3 (2001), 1611–1617.
110. Labasi, J.M., Petrushova, N., Donovan, C., McCurdy, S., Lira, P., Payette, M.M., Brissette, W., Wicks, J.R., Audoly, L., Gabel, C.A., Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 168:12 (2002), 6436–6445.
111. Latini, S., Pedata, F., Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 79:3 (2001), 463–484.
112. Lazarowski, E.R., Vesicular and conductive mechanisms of nucleotide release. Purinergic Signal 8:3 (2012), 359–373.
113. Leal, D.B., Streher, C.A., Bertoncheli Cde, M., Carli, L.F., Leal, C.A., da Silva, J.E., Morsch, V.M., Schetinger, M.R., HIV infection is associated with increased NTPDase activity that correlates with CD39-positive lymphocytes. Biochim. Biophys. Acta 1746:2 (2005), 129–134.
114. Ledderose, C., Bao, Y., Zhang, J., Junger, W.G., Novel method for real-time monitoring of ATP release reveals multiple phases of autocrine purinergic signalling during immune cell activation. Acta Physiol. (Oxf) 213:2 (2015), 334–345.
115. Ledoux, S., Runembert, I., Koumanov, K., Michel, J.B., Trugnan, G., Friedlander, G., Hypoxia enhances Ecto-5’-Nucleotidase activity and cell surface expression in endothelial cells: role of membrane lipids. Circ. Res. 92:8 (2003), 848–855.
116. Lee, D.M., Weinblatt, M.E., Rheumatoid arthritis. Lancet 358:9285 (2001), 903–911.
117. Leibovich, S.J., Chen, J.F., Pinhal-Enfield, G., Belem, P.C., Elson, G., Rosania, A., Ramanathan, M., Montesinos, C., Jacobson, M., Schwarzschild, M.A., Fink, J.S., Cronstein, B., Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. Am. J. Pathol. 160:6 (2002), 2231–2244.
118. Li, D., Wang, Y., Zhang, L., Luo, X., Li, J., Chen, X., Niu, H., Wang, K., Sun, Y., Wang, X., Yan, Y., Chai, W., Gartner, T.K., Liu, J., Roles of purinergic receptor P2Y, G protein-coupled 12 in the development of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 32:8 (2012), e81–89.
119. Li, W.H., Qiu, Y., Zhang, H.Q., Tian, X.X., Fang, W.G., P2Y2 receptor and egfr cooperate to promote prostate cancer cell invasion via ERK1/2 pathway. PLoS One, 10(7), 2015, e0133165.
120. Mariathasan, S., Weiss, D.S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W.P., Weinrauch, Y., Monack, D.M., Dixit, V.M., Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:7081 (2006), 228–232.
121. Marques, C.C., Castelo-Branco, M.T., Pacheco, R.G., Buongusto, F., do Rosario, A. Jr., Schanaider, A., Coutinho-Silva, R., de Souza, H.S., Prophylactic systemic P2X7 receptor blockade prevents experimental colitis. Biochim. Biophys. Acta 1842:1 (2014), 65–78.
122. McCann, F.V., McCarthy, D.C., Keller, T.M., Noelle, R.J., Characterization of a large conductance non-selective anion channel in B lymphocytes. Cell Signal 1:1 (1989), 31–44.
123. McInnes, I.B., Cruwys, S., Bowers, K., Braddock, M., Targeting the P2X7 receptor in rheumatoid arthritis: biological rationale for P2X7 antagonism. Clin. Exp. Rheumatol. 32:6 (2014), 878–882.
124. McRae, J.L., Russell, P.A., Chia, J.S., Dwyer, K.M., Overexpression of CD39 protects in a mouse model of preeclampsia. Nephrol. Carlt. 18:5 (2013), 351–355.
125. Melgert, B.N., Spaans, F., Borghuis, T., Klok, P.A., Groen, B., Bolt, A., de Vos, P., van Pampus, M.G., Wong, T.Y., van Goor, H., Bakker, W.W., Faas, M.M., Pregnancy and preeclampsia affect monocyte subsets in humans and rats. PLoS One, 7(9), 2012, e45229.
126. Montes, G.C., Hammes, N., da Rocha, M.D., Montagnoli, T.L., Fraga, C.A., Barreiro, E.J., Sudo, R.T., Zapata-Sudo, G., Treatment with adenosine receptor agonist ameliorates pain induced by acute and chronic inflammation. J. Pharmacol. Exp. Ther. 358:2 (2016), 315–323.
127. Muller-Haegele, S., Muller, L., Whiteside, T.L., Immunoregulatory activity of adenosine and its role in human cancer progression. Expert Rev. Clin. Immunol. 10:7 (2014), 897–914.
128. Muller, D.J., Hand, G.M., Engel, A., Sosinsky, G.E., Conformational changes in surface structures of isolated connexin 26 gap junctions. EMBO J. 21:14 (2002), 3598–3607.
129. Mulryan, K., Gitterman, D.P., Lewis, C.J., Vial, C., Leckie, B.J., Cobb, A.L., Brown, J.E., Conley, E.C., Buell, G., Pritchard, C.A., Evans, R.J., Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403:6765 (2000), 86–89.
130. Neves, A.R., Castelo-Branco, M.T., Figliuolo, V.R., Bernardazzi, C., Buongusto, F., Yoshimoto, A., Nanini, H.F., Coutinho, C.M., Carneiro, A.J., Coutinho-Silva, R., de Souza, H.S., Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease. Inflamm. Bowel Dis. 20:3 (2014), 444–457.
131. Nikolova, M., Carriere, M., Jenabian, M.A., Limou, S., Younas, M., Kok, A., Hue, S., Seddiki, N., Hulin, A., Delaneau, O., Schuitemaker, H., Herbeck, J.T., Mullins, J.I., Muhtarova, M., Bensussan, A., Zagury, J.F., Lelievre, J.D., Levy, Y., CD39/adenosine pathway is involved in AIDS progression. PLoS Pathog., 7(7), 2011, e1002110.
132. Nuttle, L.C., Dubyak, G.R., Differential activation of cation channels and non-selective pores by macrophage P2z purinergic receptors expressed in Xenopus oocytes. J. Biol. Chem. 269:19 (1994), 13988–13996.
133. Ochaion, A., Bar-Yehuda, S., Cohen, S., Barer, F., Patoka, R., Amital, H., Reitblat, T., Reitblat, A., Ophir, J., Konfino, I., Chowers, Y., Ben-Horin, S., Fishman, P., The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease. Cell Immunol. 258:2 (2009), 115–122.
134. Ohta, A., Kini, R., Ohta, A., Subramanian, M., Madasu, M., Sitkovsky, M., The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway. Front. Immunol., 3, 2012, 190.
135. Ohta, A., Ohta, A., Madasu, M., Kini, R., Subramanian, M., Goel, N., Sitkovsky, M., A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments. J. Immunol. 183:9 (2009), 5487–5493.
136. Ontyd, J., Schrader, J., Measurement of adenosine, inosine, and hypoxanthine in human plasma. J. Chromatogr. 307:2 (1984), 404–409.
137. Orriss, I., Syberg, S., Wang, N., Robaye, B., Gartland, A., Jorgensen, N., Arnett, T., Boeynaems, J.M., Bone phenotypes of P2 receptor knockout mice. Front. Biosci. Sch. Ed. 3 (2011), 1038–1046.
138. Paoletti, A., Raza, S.Q., Voisin, L., Law, F., Pipoli da Fonseca, J., Caillet, M., Kroemer, G., Perfettini, J.L., Multifaceted roles of purinergic receptors in viral infection. Microbes Infect. 14:14 (2012), 1278–1283.
139. Parry, G.C., Mackman, N., Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J. Immunol. 159:11 (1997), 5450–5456.
140. Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V., Di Virgilio, F., Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One, 3(7), 2008, e2599.
141. Pennings, M., Meurs, I., Ye, D., Out, R., Hoekstra, M., Van Berkel, T.J., Van Eck, M., Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development. FEBS Lett. 580:23 (2006), 5588–5596.
142. Ralevic, V., Burnstock, G., Receptors for purines and pyrimidines. Pharmacol. Rev. 50:3 (1998), 413–492.
143. Rath-Wolfson, L., Bar-Yehuda, S., Madi, L., Ochaion, A., Cohen, S., Zabutti, A., Fishman, P., IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis. Clin. Exp. Rheumatol. 24:4 (2006), 400–406.
144. Redman, C.W., Sargent, I.L., Latest advances in understanding preeclampsia. Science 308:5728 (2005), 1592–1594.
145. Reiss, A.B., Glass, A.D., Atherosclerosis: immune and inflammatory aspects. J. Investig. Med. 54:3 (2006), 123–131.
146. Reiss, A.B., Rahman, M.M., Chan, E.S., Montesinos, M.C., Awadallah, N.W., Cronstein, B.N., Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages. J. Leukoc. Biol. 76:3 (2004), 727–734.
147. Riquelme, G., Placental chloride channels: a review. Placenta 30:8 (2009), 659–669.
148. Robertson, J., Lang, S., Lambert, P.A., Martin, P.E., Peptidoglycan derived from Staphylococcus epidermidis induces Connexin43 hemichannel activity with consequences on the innate immune response in endothelial cells. Biochem. J. 432:1 (2010), 133–143.
149. Ruffell, B., DeNardo, D.G., Affara, N.I., Coussens, L.M., Lymphocytes in cancer development: polarization towards pro-tumor immunity. Cytokine Growth Factor Rev. 21:1 (2010), 3–10.
150. Ryan, L.M., Rachow, J.W., McCarty, B.A., McCarty, D.J., Adenosine triphosphate levels in human plasma. J. Rheumatol. 23:2 (1996), 214–219.
151. Ryan, L.M., Rachow, J.W., McCarty, D.J., Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate. J. Rheumatol. 18:5 (1991), 716–720.
152. Sabirov, R.Z., Okada, Y., Wide nanoscopic pore of maxi-anion channel suits its function as an ATP-conductive pathway. Biophys. J. 87:3 (2004), 1672–1685.
153. Salvatore, C.A., Tilley, S.L., Latour, A.M., Fletcher, D.S., Koller, B.H., Jacobson, M.A., Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J. Biol. Chem. 275:6 (2000), 4429–4434.
154. Sandilos, J.K., Chiu, Y.H., Chekeni, F.B., Armstrong, A.J., Walk, S.F., Ravichandran, K.S., Bayliss, D.A., Pannexin 1, an ATP release channel, is activated by caspase cleavage of its pore-associated C-terminal autoinhibitory region. J. Biol. Chem. 287:14 (2012), 11303–11311.
155. Schenk, U., Frascoli, M., Proietti, M., Geffers, R., Traggiai, E., Buer, J., Ricordi, C., Westendorf, A.M., Grassi, F., ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci Signal, 4(162), 2011, ra12.
156. Schlichter, L.C., Grygorczyk, R., Pahapill, P.A., Grygorczyk, C., A large, multiple-conductance chloride channel in normal human T lymphocytes. Pflugers Arch. 416:4 (1990), 413–421.
157. Schnurr, M., Toy, T., Stoitzner, P., Cameron, P., Shin, A., Beecroft, T., Davis, I.D., Cebon, J., Maraskovsky, E., ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling. Blood 102:2 (2003), 613–620.
158. Schulze, T.J., Weiss, C., Luhm, J., Brockmann, C., Gorg, S., Hennig, H., Preanalytical stability of HIV-1 and HCV RNA: impact of storage and plasma separation from cells on blood donation testing by NAT. Transfus. Med. 21:2 (2011), 99–106.
159. Semenza, G.L., Angiogenesis in ischemic and neoplastic disorders. Annu. Rev. Med. 54 (2003), 17–28.
160. Seror, C., Melki, M.T., Subra, F., Raza, S.Q., Bras, M., Saidi, H., Nardacci, R., Voisin, L., Paoletti, A., Law, F., Martins, I., Amendola, A., Abdul-Sater, A.A., Ciccosanti, F., Delelis, O., Niedergang, F., Thierry, S., Said-Sadier, N., Lamaze, C., Metivier, D., Estaquier, J., Fimia, G.M., Falasca, L., Casetti, R., Modjtahedi, N., Kanellopoulos, J., Mouscadet, J.F., Ojcius, D.M., Piacentini, M., Gougeon, M.L., Kroemer, G., Perfettini, J.L., Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection. J. Exp. Med. 208:9 (2011), 1823–1834.
161. Smart, M.L., Gu, B., Panchal, R.G., Wiley, J., Cromer, B., Williams, D.A., Petrou, S., P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J. Biol. Chem. 278:10 (2003), 8853–8860.
162. Spaans, F., de Vos, P., Bakker, W.W., van Goor, H., Faas, M.M., Danger signals from ATP and adenosine in pregnancy and preeclampsia. Hypertension 63:6 (2014), 1154–1160.
163. Spaans, F., Melgert, B.N., Borghuis, T., Klok, P.A., de Vos, P., Bakker, W.W., van Goor, H., Faas, M.M., Extracellular adenosine triphosphate affects systemic and kidney immune cell populations in pregnant rats. Am. J. Reprod. Immunol. 72:3 (2014), 305–316.
164. Spaans, F., Melgert, B.N., Chiang, C., Borghuis, T., Klok, P.A., de Vos, P., van Goor, H., Bakker, W.W., Faas, M.M., Extracellular ATP decreases trophoblast invasion, spiral artery remodeling and immune cells in the mesometrial triangle in pregnant rats. Placenta 35:8 (2014), 587–595.
165. Sridharan, M., Adderley, S.P., Bowles, E.A., Egan, T.M., Stephenson, A.H., Ellsworth, M.L., Sprague, R.S., Pannexin 1 is the conduit for low oxygen tension-induced ATP release from human erythrocytes. Am. J. Physiol. Heart Circ. Physiol. 299:4 (2010), H1146–H1152.
166. Stachon, P., Geis, S., Peikert, A., Heidenreich, A., Michel, N.A., Unal, F., Hoppe, N., Dufner, B., Schulte, L., Marchini, T., Cicko, S., Ayata, K., Zech, A., Wolf, D., Hilgendorf, I., Willecke, F., Reinohl, J., von Zur Muhlen, C., Bode, C., Idzko, M., Zirlik, A., Extracellular ATP induces vascular inflammation and atherosclerosis via purinergic receptor Y2 in mice. Arterioscler. Thromb. Vasc. Biol. 36:8 (2016), 1577–1586.
167. Stachon, P., Peikert, A., Michel, N.A., Hergeth, S., Marchini, T., Wolf, D., Dufner, B., Hoppe, N., Ayata, C.K., Grimm, M., Cicko, S., Schulte, L., Reinohl, J., von zur Muhlen, C., Bode, C., Idzko, M., Zirlik, A., P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 34:10 (2014), 2237–2245.
168. Stagg, J., Divisekera, U., McLaughlin, N., Sharkey, J., Pommey, S., Denoyer, D., Dwyer, K.M., Smyth, M.J., Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc. Natl. Acad. Sci. U. S. A. 107:4 (2010), 1547–1552.
169. Stagg, J., Smyth, M.J., Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 29:39 (2010), 5346–5358.
170. Stary, H.C., Chandler, A.B., Glagov, S., Guyton, J.R., Insull, W. Jr., Rosenfeld, M.E., Schaffer, S.A., Schwartz, C.J., Wagner, W.D., Wissler, R.W., A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89:5 (1994), 2462–2478.
171. Sun, X., Wu, Y., Gao, W., Enjyoji, K., Csizmadia, E., Muller, C.E., Murakami, T., Robson, S.C., CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice. Gastroenterology 139:3 (2010), 1030–1040.
172. Surprenant, A., North, R.A., Signaling at purinergic P2X receptors. Annu. Rev. Physiol. 71 (2009), 333–359.
173. Synnestvedt, K., Furuta, G.T., Comerford, K.M., Louis, N., Karhausen, J., Eltzschig, H.K., Hansen, K.R., Thompson, L.F., Colgan, S.P., Ecto-5’-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110:7 (2002), 993–1002.
174. Takenaka, M.C., Robson, S., Quintana, F.J., Regulation of the T Cell response by CD39. Trends Immunol. 37:7 (2016), 427–439.
175. Taylor, J.M., Han, Z., Purinergic receptor functionality is necessary for infection of human hepatocytes by hepatitis delta virus and hepatitis B virus. PLoS One, 5(12), 2010, e15784.
176. Teng, B., Smith, J.D., Rosenfeld, M.E., Robinet, P., Davis, M.E., Morrison, R.R., Mustafa, S.J., A(1) adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice. Cardiovasc Res. 102:1 (2014), 157–165.
177. Tokunaga, A., Tsukimoto, M., Harada, H., Moriyama, Y., Kojima, S., Involvement of SLC17A9-dependent vesicular exocytosis in the mechanism of ATP release during T cell activation. J. Biol. Chem. 285:23 (2010), 17406–17416.
178. Trabanelli, S., Ocadlikova, D., Gulinelli, S., Curti, A., Salvestrini, V., Vieira, R.P., Idzko, M., Di Virgilio, F., Ferrari, D., Lemoli, R.M., Extracellular ATP exerts opposite effects on activated and regulatory CD4+ T cells via purinergic P2 receptor activation. J. Immunol. 189:3 (2012), 1303–1310.
179. Tsukimoto, M., Maehata, M., Harada, H., Ikari, A., Takagi, K., Degawa, M., P2X7 receptor-dependent cell death is modulated during murine T cell maturation and mediated by dual signaling pathways. J. Immunol. 177:5 (2006), 2842–2850.
180. Varani, K., Massara, A., Vincenzi, F., Tosi, A., Padovan, M., Trotta, F., Borea, P.A., Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate. Arthritis Rheum. 60:10 (2009), 2880–2891.
181. Wang, H., Zhang, W., Tang, R., Zhu, C., Bucher, C., Blazar, B.R., Geng, J.G., Zhang, C., Linden, J., Wu, C., Huo, Y., Adenosine receptor A2A deficiency in leukocytes increases arterial neointima formation in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 30:5 (2010), 915–922.
182. Wang, H., Zhang, W., Zhu, C., Bucher, C., Blazar, B.R., Zhang, C., Chen, J.F., Linden, J., Wu, C., Huo, Y., Inactivation of the adenosine A2A receptor protects apolipoprotein E-deficient mice from atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29:7 (2009), 1046–1052.
183. Weber, F.C., Esser, P.R., Muller, T., Ganesan, J., Pellegatti, P., Simon, M.M., Zeiser, R., Idzko, M., Jakob, T., Martin, S.F., Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity. J. Exp. Med. 207:12 (2010), 2609–2619.
184. Wilhelm, K., Ganesan, J., Muller, T., Durr, C., Grimm, M., Beilhack, A., Krempl, C.D., Sorichter, S., Gerlach, U.V., Juttner, E., Zerweck, A., Gartner, F., Pellegatti, P., Di Virgilio, F., Ferrari, D., Kambham, N., Fisch, P., Finke, J., Idzko, M., Zeiser, R., Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R. Nat. Med. 16:12 (2010), 1434–1438.
185. Wilkin, F., Duhant, X., Bruyns, C., Suarez-Huerta, N., Boeynaems, J.M., Robaye, B., The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J. Immunol. 166:12 (2001), 7172–7177.
186. Wiviott, S.D., Braunwald, E., McCabe, C.H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.J., Ardissino, D., De Servi, S., Murphy, S.A., Riesmeyer, J., Weerakkody, G., Gibson, C.M., Antman, E.M., Investigators, T.-T., Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 357:20 (2007), 2001–2015.
187. Woehrle, T., Yip, L., Manohar, M., Sumi, Y., Yao, Y., Chen, Y., Junger, W.G., Hypertonic stress regulates T cell function via pannexin-1 hemichannels and P2X receptors. J. Leukoc. Biol. 88:6 (2010), 1181–1189.
188. Wong, C.W., Christen, T., Roth, I., Chadjichristos, C.E., Derouette, J.P., Foglia, B.F., Chanson, M., Goodenough, D.A., Kwak, B.R., Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat. Med. 12:8 (2006), 950–954.
189. Xie, R., Xu, J., Wen, G., Jin, H., Liu, X., Yang, Y., Ji, B., Jiang, Y., Song, P., Dong, H., Tuo, B., The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP. J. Biol. Chem. 289:27 (2014), 19137–19149.
190. Xing, S., Grol, M.W., Grutter, P.H., Dixon, S.J., Komarova, S.V., Modeling interactions among individual P2 receptors to explain complex response Patterns over a wide range of ATP concentrations. Front. Physiol., 7, 2016, 294.
191. Yan, D., Zhu, Y., Walsh, T., Xie, D., Yuan, H., Sirmaci, A., Fujikawa, T., Wong, A.C., Loh, T.L., Du, L., Grati, M., Vlajkovic, S.M., Blanton, S., Ryan, A.F., Chen, Z.Y., Thorne, P.R., Kachar, B., Tekin, M., Zhao, H.B., Housley, G.D., King, M.C., Liu, X.Z., Mutation of the ATP-gated P2X(2) receptor leads to progressive hearing loss and increased susceptibility to noise. Proc. Natl. Acad. Sci. U. S. A. 110:6 (2013), 2228–2233.
192. Yaron, J.R., Gangaraju, S., Rao, M.Y., Kong, X., Zhang, L., Su, F., Tian, Y., Glenn, H.L., Meldrum, D.R., K(+) regulates Ca(2+) to drive inflammasome signaling: dynamic visualization of ion flux in live cells. Cell Death Dis., 6, 2015, e1954.
193. Yashiro, K., Matsumoto, Y., Ihara, H., Suzuki, Y., Kondo, K., Urano, T., Umemura, K., Involvement of platelet activation by P2Y12 receptor in the development of transplant arteriosclerosis in mice. Transplantation 87:5 (2009), 660–667.
194. Yegutkin, G.G., Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim. Biophys. Acta 1783:5 (2008), 673–694.
195. Yip, L., Woehrle, T., Corriden, R., Hirsh, M., Chen, Y., Inoue, Y., Ferrari, V., Insel, P.A., Junger, W.G., Autocrine regulation of T-cell activation by ATP release and P2X7 receptors. FASEB J. 23:6 (2009), 1685–1693.
196. Yoneyama, Y., Sawa, R., Suzuki, S., Ishino, H., Miura, A., Kuwabara, Y., Kuwajima, T., Ito, N., Kiyokawa, Y., Otsubo, Y., Araki, T., Regulation of plasma adenosine levels in normal pregnancy. Gynecol. Obstet. Invest. 53:2 (2002), 71–74.
197. Yoneyama, Y., Suzuki, S., Sawa, R., Yoneyama, K., Power, G.G., Araki, T., Increased plasma adenosine concentrations and the severity of preeclampsia. Obstet. Gynecol. 100:6 (2002), 1266–1270.
198. Zhou, R., Tardivel, A., Thorens, B., Choi, I., Tschopp, J., Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11:2 (2010), 136–140.